维普期刊资源整合服务平台（V6.5）

160篇 您的检索式：作者名="Bodoky"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial显示文摘	Florian Lordick Yoon-Koo Kang Hyun-Cheol Chung Pamela Salman Sang Cheul Oh Gy?rgy Bodoky Galina Kurteva Constantin Volovat Vladimir M Moiseyenko Vera Gorbunova Joon Oh Park Akira Sawaki Ilhan Celik Heiko G?tte Helena Melezínková Markus Moehler	2013	Lancet Oncology2013，，6：	14
2	ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology显示文摘	J. Arends G. Bodoky F. Bozzetti K. Fearon M. Muscaritoli G. Selga M.A.E. van Bokhorst-de van der Schueren M. von Meyenfeldt G. Zürcher R. Fietkau E. Aulbert B. Frick M. Holm M. Kneba H.J. Mestrom A. Zander	2006	Clinical Nutrition2006，，2：	6
3	Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial显示文摘	Hansjochen Wilke Kei Muro Eric Van Cutsem Sang-Cheul Oh Gy?rgy Bodoky Yasuhiro Shimada Shuichi Hironaka Naotoshi Sugimoto Oleg Lipatov Tae-You Kim David Cunningham Philippe Rougier Yoshito Komatsu Jaffer Ajani Michael Emig Roberto Carlesi David Ferry Kuma	2014	Lancet Oncology2014，，11：	4
4	Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial显示文摘	Aimery de Gramont Eric Van Cutsem Hans-Joachim Schmoll Josep Tabernero Stephen Clarke Malcolm J Moore David Cunningham Thomas H Cartwright J Randolph Hecht Fernando Rivera Seock-Ah Im Gy?rgy Bodoky Ramon Salazar Frédérique Maindrault-Goebel Einat Shacham-	2012	Lancet Oncology2012，，12：	3
5	Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study显示文摘	J.A. Ajani M. Buyse M. Lichinitser V. Gorbunova G. Bodoky J.Y. Douillard S. Cascinu V. Heinemann R. Zaucha A. Carrato D. Ferry V. Moiseyenko	2013	European Journal of Cancer2013，，：	3
6	A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy显示文摘	Gy?rgy Bodoky Constanta Timcheva David Spigel Phillip Stella Tudor Ciuleanu G. Pover N. Tebbutt	2012	Investigational New Drugs2012，，3：	2
7	Multieenter phase III comparison of cisplatin/S-I with eisplatin/infusional fluoroura- eil in advanced gastric or gastroesophageal adenocarcinoma study:the FLAGS trial显示文摘	Ajani JA Rodriguez W Bodoky G	2010	J Clin Oncol2010，28，9：	1
8	Chiral recognition and quantification of propranolol enantiomers by surface enhanced Raman scattering through supramolecular in- teraction with 3-cyclodextrin 显示文摘	Bodoki E Oltean M Bodoki A	2012	Talanta2012，101，：	1
9	Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study:the FLAGS trial显示文摘	Ajani JA Rodriguez W Bodoky G	2010	J Clin Oncol2010，28，9：	1
10	Effect of enteral nutrition on exocrine pancreat ic function显示文摘	Harsanyi L Pap A	1991	Am J Surg1991，161，1：	1
11	Multicenter phase IIIcomparison of cisplatin/S-1(CS)with cisplatin/5-FU(CF)as first-line therapy in patients with advanced gastric cancer(FLAGS):Secondary and subset analyses显示文摘	Ajani JA Rodriquez W Bodoky G	2009	J Clin Oncol2009，27，15：	1
12	Multicenter phase Ⅲ comparison of cisplatin/S-1 (CS) with cisplatin/5-FU (CF) as first-line therapy in patients with advanced gastric cancer (FLAGS): Secondary and subset analyses 显示文摘	Ajani JA Rodriquez W Bodoky G	2009	J Clin Oncol (Meeting Abstracts)2009，27，15：	1
13	ESPEN Guidelines on En- teral Nutritionz Non- surgical oncology显示文摘	Arends J Bodoky G Bozzetti F	2006	Clin Nutr2006，25，2：	1
14	Clinical benefit and health - related quality of life assessment in patients treated with cisplatin/S - 1 versus cisplati~5 - FU : Secondary end point results from the first -line advanced gastric cancer study (FLAGS) 显示文摘	BODOKY G SCHEULEN M E RIVERA F	2015	J Gastrointest Cancer2015，46，2：	1
15	C, emcitabine plus capeeitabine compared with gemeitabine alone in advanced pan- creatic cancer: a randomized, muhicenter, phase Ⅲ trial of the Swiss Group for Clinical Cancer Research and the Central Euro- pearl Cooperative Oncology Group 显示文摘	Herrmann R Bodoky G Ruhstaller T	2007	J Clin Oncol2007，25，：	1
16	Effect of enteral nutrition on exocrine pancreatic function显示文摘	Bodoky G Harsangi L Pap A	1991	Am J Surg1991，161，：	1
17	Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer(EXPAND):a randomised, open-label phase 3 trial显示文摘	Lordick F Kang Y K Chung H C Salman P Oh S C Bodoky G	2013	Lancet Oncol2013，14，：	1
18	Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer : a randomized, multicenter, phase Ⅲ trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group 显示文摘	Herrmann R Bodoky G Ruhstaller T	2007	J Clin Oncol2007，25，16：	1
19	Antibiotic prophylaxis with two doses of cephalosporin in patients managed with internal fixation for a fracture of the hip 显示文摘	Bodoky A Neff U Heberer M	1993	J Bone Joint Surg Am1993，75，：	1
20	Effect of enteral nutrition on exocrine pancreatic function显示文摘	Bodoky G Harsanyi L Pap A	1991	Am J Surg1991，161，：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示